Fluticasone (Flixotide) 250 mcg accuhaler: Stock issue resolved

GSK, the supplier of fluticasone (Flixotide) 250mcg accuhaler, had a short out of stock in September 2020.

On this page

Supply issue resolved

A supply of fluticasone (Flixotide) 250 mcg has been available from early October.

There was no stock shortage of the lower strength Flixotide 100mcg and 50mcg accuhalers, or the Flixotide 250 mcg metered dose inhaler (MDI).

Clinical advice for the shortage

Our experts on respiratory health advised that:

  • two inhalations of the 100 mcg accuhaler would deliver 200 mcg, which they consider would be as clinically effective as one inhalation of the 250mcg accuhaler; or
  • the Flixotide 250 mcg MDI would be an appropriate alternative for people who can change device type.

We received the advice from the Respiratory Subcommittee of the Pharmacology and Therapeutics Advisory Committee (PTAC).

Find a list of the members of the respiratory subcommittee